2017
DOI: 10.2147/ndt.s149067
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders

Abstract: ObjectivesMitochondrial disorders (MIDs) frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or evolve into MIMODS during the course. This study aimed to find which organs and/or tissues are most frequently affected by MIMODS, which are the most frequent abnormalities within an affected organ, whether there are typical MIMODS patterns, and to generate an MIMODS score to assess the diagnostic probability for an MID.MethodsThis is a retrospective evaluation of clinical, biochemical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
19
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 89 publications
0
19
0
Order By: Relevance
“…Magnetic resonance imaging angiography was scheduled, but the patient received a DNR order and died during the further course before the investigation and work‐up for MID could have been carried out. Based upon the history, the clinical examination, the instrumental investigations, and the MIMODS score (n = 43) (see Appendix ), MIMODS was diagnosed.…”
Section: Case Reportmentioning
confidence: 99%
“…Magnetic resonance imaging angiography was scheduled, but the patient received a DNR order and died during the further course before the investigation and work‐up for MID could have been carried out. Based upon the history, the clinical examination, the instrumental investigations, and the MIMODS score (n = 43) (see Appendix ), MIMODS was diagnosed.…”
Section: Case Reportmentioning
confidence: 99%
“…Though we agree that immune cells may be affected in patients with a mitochondrial disorder (MID), MIDs usually manifest as a multiorgan syndrome, affecting the brain, muscles, peripheral nerves, eyes, ears, endocrine organs, the myocardium, the gastrointestinal tract, the lungs, the kidneys, the blood cells, the cartilage, and the skin in addition to the immune cells . Thus, it is important to prospectively investigate carriers of mtDNA mutations for clinical or subclinical involvement of the other organs.…”
mentioning
confidence: 99%
“…A shortcoming of the study is that clinical severity of mtDNA‐related mitochondrial disorders (MIDs) in group 1 was not correlated with the Newcastle Mitochondrial Disease Scale for adults or with the Mitochondrial Multiorgan Disorders Syndrome score . We should be informed if frequency and severity of obstetric complications correlated with either of these scores.…”
mentioning
confidence: 99%